Executive Profile*

Keith R. Yamamoto Ph.D.

AgeTotal Calculated CompensationThis person is connected to 37 board members in 5 different organizations across 3 different industries.

See Board Relationships


Dr. Keith R. Yamamoto, Ph.D., founded the journal Molecular Biology of the Cell and served as an Associate Editor, Editor, and Editor-in-Chief from 1989 to 2003. Dr. Yamamoto has been the Chairman of Scientific Advisory Board and Member of Scientific Advisory Board of Sirna Therapeutics Inc. from March 2005 to 2007. He oversees the Yamamoto Lab, which is interested in mechanisms by which gene transcription is regulated in different cell types and physiological (or pathological) ...

Read Full Background

Corporate Headquarters*

Princeton University
Princeton, New Jersey 08544

United States

Phone: 609-258-3000
Fax: 609-258-6743

Board Members Memberships*

There is no Board Members Memberships data available.


Princeton University
Post-Doctoral Training
University of California-San Francisco
Bachelor's Degree 1968
Iowa State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


John Michael Maslowski Chief Executive Officer and Director
Fibrocell Science, Inc.
Kenneth T. Mills Chief Executive Officer, President, Director and Member of Disclosure Committee
Regenxbio Inc.
Matthew Kapusta Chief Executive Officer and Member of Management Board
uniQure N.V.
Katrine S. Bosley Chief Executive Officer, President and Director
Editas Medicine, Inc.
Steven M. Paul M.D.Chief Executive Officer, President and Director
Voyager Therapeutics, Inc.
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.